Components of the IFN-gamma signaling pathway in tumorigenesis
- PMID: 12098930
Components of the IFN-gamma signaling pathway in tumorigenesis
Abstract
Many features of the interferon gamma (IFN-gamma) signaling pathway would suggest that it is anti-tumorigenic. The IFN-gamma signaling pathway leads to apoptosis and to the expression of immune function proteins that could cooperate with T cells in the destruction of tumor. Various lines of experimental approach have, in general, supported the hypothesis that the IFN-gamma signaling pathway is anti-tumorigenic. However, data also indicate that the idea that the IFN-gamma signaling pathway is exclusively anti-tumorigenic is too simplistic. Also, to date, very little of the knowledge regarding the anti-tumor effects of the IFN-gamma pathway has been useful in the prognosis or therapy of cancer. This review summarizes the current state of knowledge regarding the IFN-gamma signaling pathway in tumorigenesis, with an emphasis on MHC class II induction in tumor cells and the induction of apoptosis in tumor cells. The review also indicates some future areas of investigation that offer hope for applying this knowledge in reducing cancer mortality.
Similar articles
-
IFN-gamma/JAK/STAT pathway-induced inhibition of DR4 and DR5 expression on endothelial cells is cancelled by cycloheximide-sensitive mechanism: novel finding of cycloheximide-regulating death receptor expression.Int J Mol Med. 2005 May;15(5):833-9. Int J Mol Med. 2005. PMID: 15806306
-
Stat1-dependent induction of tumor necrosis factor-related apoptosis-inducing ligand and the cell-surface death signaling pathway by interferon beta in human cancer cells.Cancer Res. 2003 Sep 1;63(17):5299-307. Cancer Res. 2003. PMID: 14500361
-
Epigenetic silencing of the CIITA gene and posttranscriptional regulation of class II MHC genes in ocular melanoma cells.Invest Ophthalmol Vis Sci. 2004 Sep;45(9):3185-95. doi: 10.1167/iovs.04-0111. Invest Ophthalmol Vis Sci. 2004. PMID: 15326139
-
Interferon-gamma: biologic functions and HCV therapy (type I/II) (1 of 2 parts).Clin Ter. 2006 Jul-Aug;157(4):377-86. Clin Ter. 2006. Retraction in: Clin Ter. 2008 May-Jun;159(3):207. PMID: 17051976 Retracted. Review.
-
Recent progress in the elucidation of interferon-gamma actions: molecular biology and biological functions.Int Arch Allergy Immunol. 1994 Aug;104(4):311-6. doi: 10.1159/000236685. Int Arch Allergy Immunol. 1994. PMID: 8038608 Review.
Cited by
-
MHC class II associated stomach cancer mutations correlate with lack of subsequent tumor development.Mol Clin Oncol. 2017 Dec;7(6):1119-1121. doi: 10.3892/mco.2017.1432. Epub 2017 Sep 29. Mol Clin Oncol. 2017. PMID: 29285385 Free PMC article.
-
Dysregulation of helper T lymphocytes in esophageal squamous cell carcinoma (ESCC) patients is highly associated with aberrant production of miR-21.Immunol Res. 2019 Jun;67(2-3):212-222. doi: 10.1007/s12026-019-09079-7. Immunol Res. 2019. PMID: 31278653
-
Anti-tumor effect of pEgr-IFNgamma gene-radiotherapy in B16 melanoma-bearing mice.World J Gastroenterol. 2004 Oct 15;10(20):3011-5. doi: 10.3748/wjg.v10.i20.3011. World J Gastroenterol. 2004. PMID: 15378784 Free PMC article.
-
Ifngr1 and Stat1 mediated canonical Ifn-γ signaling drives nigrostriatal degeneration.Neurobiol Dis. 2018 Feb;110:133-141. doi: 10.1016/j.nbd.2017.11.007. Epub 2017 Nov 28. Neurobiol Dis. 2018. PMID: 29196213 Free PMC article.
-
Combination of hTERT knockdown and IFN-gamma treatment inhibited angiogenesis and tumor progression in glioblastoma.Clin Cancer Res. 2009 Dec 1;15(23):7186-95. doi: 10.1158/1078-0432.CCR-09-1425. Epub 2009 Nov 24. Clin Cancer Res. 2009. PMID: 19934306 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Research Materials
Miscellaneous